Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 186

    1.

    Effect of testosterone therapy versus other factors on the self-reported sexual satisfaction of premenopausal women.

    Kumar H, Muthukrishnan J, Modi KD.

    Ann Intern Med. 2008 Sep 2;149(5):361; author reply 361-2. No abstract available. PMID: 18765711 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of Testosterone therapy versus other factors on the self-reported sexual satisfaction of premenopausal women.

    Hong L, Wu K, Fan D.

    Ann Intern Med. 2008 Sep 2;149(5):361; author reply 361-2. No abstract available. PMID: 18765712 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial.

    Davis S, Papalia MA, Norman RJ, O'Neill S, Redelman M, Williamson M, Stuckey BG, Wlodarczyk J, Gard'ner K, Humberstone A.

    Ann Intern Med. 2008 Apr 15;148(8):569-77.PMID: 18413618 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Testosterone supplementation to improve women's sexual satisfaction: complexities and unknowns.

    Basson R.

    Ann Intern Med. 2008 Apr 15;148(8):620-1. No abstract available. PMID: 18413624 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.

    Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S.

    J Clin Endocrinol Metab. 2005 Sep;90(9):5226-33. Epub 2005 Jul 12.PMID: 16014407 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.

    Kingsberg S, Shifren J, Wekselman K, Rodenberg C, Koochaki P, Derogatis L.

    J Sex Med. 2007 Jul;4(4 Pt 1):1001-8.PMID: 17627745 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Is there a pharmacotherapy for libido disturbances in men?]

    Köhn FM.

    Urologe A. 2006 Aug;45(8):999-1001. Review. German. PMID: 16832642 [PubMed - indexed for MEDLINE]Related articles

    9.

    Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?

    Schover LR.

    Fertil Steril. 2008 Jul;90(1):129-40. Epub 2007 Nov 26. Review.PMID: 18023435 [PubMed - indexed for MEDLINE]Related articles

    10.

    Hormonal factors in female sexual dysfunction.

    Anastasiadis AG, Davis AR, Salomon L, Burchardt M, Shabsigh R.

    Curr Opin Urol. 2002 Nov;12(6):503-7. Review.PMID: 12409881 [PubMed - indexed for MEDLINE]Related articles

    11.

    Androgen status in healthy premenopausal women with loss of libido.

    Nyunt A, Stephen G, Gibbin J, Durgan L, Fielding AM, Wheeler M, Price DE.

    J Sex Marital Ther. 2005 Jan-Feb;31(1):73-80.PMID: 15841707 [PubMed - indexed for MEDLINE]Related articles

    12.

    Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B: Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction.

    Guay A, Jacobson J, Munarriz R, Traish A, Talakoub L, Quirk F, Goldstein I, Spark R.

    Int J Impot Res. 2004 Apr;16(2):121-9.PMID: 14973532 [PubMed - indexed for MEDLINE]Related articles

    13.

    A case series of androgen use in breast cancer survivors with sexual dysfunction.

    Krychman ML, Stelling CJ, Carter J, Hudis CA.

    J Sex Med. 2007 Nov;4(6):1769-74. Epub 2007 Jul 31.PMID: 17666036 [PubMed - indexed for MEDLINE]Related articles

    14.

    Testosterone patches for female sexual dysfunction.

    [No authors listed]

    Drug Ther Bull. 2009 Mar;47(3):30-4.PMID: 19261838 [PubMed - indexed for MEDLINE]Related articles

    15.

    To study hypoactive sexual desire disorder in a fragile X carrier female successfully treated with local testosterone application.

    Raza S, Baig M, Ali J, Rizvi S.

    Int J Impot Res. 2008 Mar-Apr;20(2):226-8. Epub 2007 Sep 13.PMID: 17851581 [PubMed - indexed for MEDLINE]Related articles

    16.

    Hormonal aspects of sexual dysfunction: the therapeutic use of exogenous androgens in men and women.

    Seidman SN.

    Curr Psychiatry Rep. 2000 Jun;2(3):215-22. Review.PMID: 11122959 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Treatment of sexual indifference and discontent in women by administration of androgens]

    Heczko P, Mohapl P.

    Cesk Gynekol. 1975 Apr;40(3):220-1. Czech. No abstract available. PMID: 1131970 [PubMed - indexed for MEDLINE]Related articles

    18.

    Testosterone for women: necessary or noxious?

    Katz A.

    AWHONN Lifelines. 2006 Jun-Jul;10(3):208-9. No abstract available. PMID: 16792707 [PubMed - indexed for MEDLINE]Related articles

    19.

    Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women.

    Kingsberg S.

    J Sex Med. 2007 Mar;4 Suppl 3:227-34. Review.PMID: 17394595 [PubMed - indexed for MEDLINE]Related articles

    20.

    Editorial comments on "the current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women".

    Goldstein I.

    J Sex Med. 2008 Sep 2;5 Suppl 4:177-8. No abstract available. PMID: 18783531 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data